Transmission and prevalence of drug-resistant tuberculosis in a Brazilian setting under a directly observed therapy short-course strategy

Latrilha, Fábio Oliveira; Simonsen, Vera; Pinhata, Juliana Maira Watanabe; Brandão, Angela Pires; Galesi, Vera Maria Neder; Waldman, Eliseu Alves; Ferrazoli, Lucilaine.
Rev. Soc. Bras. Med. Trop ; 53: e20190404, 2020. tab, graf
Artículo en Inglés | SES-SP, Coleciona SUS (Brasil), LILACS | ID: biblio-1136910

Documentos relacionados

  1. Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping.
  2. Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India.
  3. Improving tuberculosis surveillance by detecting international transmission using publicly available whole genome sequencing data.
  4. Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot study.
  5. Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
  6. How has the municipal availability of the GeneXpert®MTB/RIF system affected the detection of drug-resistant tuberculosis in Brazil?
  7. Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study.
  8. Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait-Papua New Guinea cross-border region.
  9. Quantifying Mycobacterium tuberculosis Transmission Dynamics Across Global Settings: A Systematic Analysis.
  10. Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.